Lenvatinib

Definition of lenvatinib mesylate
National Cancer Institute

lenvatinib mesylate

(len-VA-tih-nib MEH-zih-layt)
A drug used alone or with other drugs to treat certain types of endometrial cancer, renal cell carcinoma (a type of kidney cancer), hepatocellular carcinoma (a type of liver cancer), and thyroid cancer. It is also being studied in the treatment of other types of cancer. Lenvatinib mesylate blocks certain proteins, which may help keep cancer cells from growing and may kill them. It may also prevent the growth of new blood vessels that tumors need to grow. Lenvatinib mesylate is a type of tyrosine kinase inhibitor and a type of antiangiogenesis agent. Also called Lenvima.

Source: NCI Dictionary of Cancer Terms